Bill of Health

JANUARY 12, 2023

Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement. Moderna also licensed their mRNA technology from Cellscript LLC – University of Pennsylvania’s successor-in-interest to the 966 patent.

COVID-19 Vaccine 318

COVID-19 Vaccine COVID-19 Licensing Governance 318

Bill of Health

OCTOBER 31, 2022

Some COVID-19 vaccine manufacturers in the US have refused to share vaccine samples for research purposes , creating an access issue with the potential to delay comparator studies, follow-on research, and new vaccine / drug development. By Aparajita Lath. However, some suggest that patents are impeding access to research.

COVID-19 173

COVID-19 COVID-19 Vaccine Licensing FDA 173

Bill of Health

JANUARY 3, 2023

Although three in four doctors support scrapping state medical boards in favor of a single federal license, such sweeping reform is likely far off. Lindsey Goehring refrains from arguing all licenses fall within the purview of the federal domain, but maintains that telemedicine would qualify as interstate commerce. By Timothy Bonis.

Licensing 130

Licensing Telemedicine Governance Federal Policy 130

Drug & Device Law

JANUARY 4, 2024

So we do have comments on the bizarre complaint that the Texas attorney general recently filed over COVID-19. The complaint, brought under the Texas consumer protection statute, sued a major manufacturer of COVID-19 vaccine that was used to control the recent pandemic. 247d-6d(b)(8). distribution, sale, . . Strike three.

COVID-19 Vaccine 59

COVID-19 Vaccine COVID-19 FDA Public Health 59